• Exchange: Frankfurt
  • Sector: Health Care
  • Industry: Medical Equipment/Devices
  • Sub-Industry: Life Science Equipment

Vermillion Inc

+ Add to Watchlist

CUL1:GR

2.003 EUR 0.101 5.31%

As of 10:45:49 ET on 04/17/2014.

Snapshot for Vermillion Inc (CUL1)

Open: 2.003 Day's Range: 2.003 - 2.003 Volume: 0
Previous Close: 1.902 52wk Range: 0.828 - 3.168 1-Yr Rtn: +140.75%

Stock Chart for CUL1

No chart data available.
  • CUL1:GR 2.003
  • 1D
  • 1M
  • 1Y
1.902
Interactive CUL1 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for CUL1

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. DAX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2014) -
Est. PEG Ratio -
Market Cap (M EUR) 71.77
Shares Outstanding (M) 35.83
30 Day Average Volume 85
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 05/13/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for CUL1

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for CUL1

Vermillion, Inc. discovers, develops, and commercializes diagnostic tests. The Company focuses in the areas of oncology, hematology, cardiology, and women's health.

Thomas H McLain "Tom"President/CEODonald G MunroeSenior VP:Business Dev
Marian E SaccoSenior VP:Sales/Chief Commercial OfcrEric J SchoenVP:Finance/Chief Acctg Ofcr/Controller
More Company Profile & Key Executives for CUL1

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisement
  • CUL1 News

  • Industry News

Advertisement
Sponsored Links
Advertisements
sec ||= nil